All articles tagged with #autoimmune diseases
A CART4-34 CAR-T therapy targets the IGHV4-34 gene in B-cell cancer, destroying lymphoma cells in mice as effectively as CD19 CAR-T while sparing healthy B cells and avoiding immune suppression; the approach could also be used to treat autoimmune conditions such as lupus, but human trials are needed.
Scientists have discovered that a small subset of maternal immune cells persist in offspring throughout life, actively maintaining immune tolerance to maternal cells and potentially influencing various health conditions, including autoimmune diseases, cancer, and neurological disorders.
The article discusses the complexities of autoimmune diseases like lupus, highlighting recent scientific advances such as CAR-T therapy and targeted drugs, which offer hope for better diagnosis, understanding, and treatment of these conditions that affect millions worldwide.
Autoimmune diseases, which can affect nearly every part of the body and are more common in women, occur when the immune system mistakenly attacks healthy tissues. There are over 100 such diseases, with symptoms ranging from mild to life-threatening, and diagnosis can be complex. Recent research offers hope for more targeted treatments and early interventions, with ongoing clinical trials showing promising results. The global market for autoimmune treatments is substantial, reflecting the widespread impact of these chronic conditions.
Autoimmune diseases, which can affect various parts of the body and are more common in women, occur when the immune system mistakenly attacks healthy tissues. They are difficult to diagnose due to vague symptoms and overlapping conditions, but new research and clinical trials are exploring treatments that aim to reprogram the immune system and delay disease onset. Despite advances, treatment remains complex and often lifelong, with ongoing efforts to improve diagnosis and develop targeted therapies.
Ruth Wilson's six-year struggle to diagnose her lupus highlights the challenges of autoimmune diseases, which affect millions and are difficult to treat. Advances in research, including new therapies like CAR-T and targeted drugs, offer hope for better diagnosis, understanding, and potentially cures, as scientists explore the complex biology and diverse subtypes of these conditions.
The article discusses the revolutionary potential of mRNA technology for treating cancer, genetic diseases, and autoimmune conditions, highlighting how US federal policies are currently hindering its development and application, risking a setback in biomedical innovation and international competitiveness.
Fred Ramsdell, a Whitefish immunologist, won the 2025 Nobel Prize in Physiology or Medicine for his work on regulatory T cells and immune tolerance, which has significant implications for treating autoimmune diseases and cancer. His journey from community college to Nobel laureate highlights his passion for impactful science and serendipitous career path, with recent advancements enabling clinical applications of his research.
A Portland-born molecular biologist, Mary E. Brunkow, along with two other scientists, won the Nobel Prize in medicine for discovering how regulatory T cells help prevent autoimmune diseases by maintaining immune system balance, a breakthrough that could lead to better treatments for conditions like diabetes and lupus.
Three scientists, Mary E. Brunkow, Fred Ramsdell, and Dr. Shimon Sakaguchi, won the Nobel Prize in medicine for their discoveries related to peripheral immune tolerance, particularly the role of regulatory T cells and the Foxp3 gene in controlling immune responses and preventing autoimmune diseases.
The Nobel Prize in Physiology or Medicine was awarded to Mary E Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking work on how the immune system is regulated to prevent it from attacking the body, laying the foundation for new treatments for cancer and autoimmune diseases.
Scientists at La Jolla Institute have revealed the first 3D structure of a human endogenous retrovirus protein, HERV-K Env, opening new avenues for diagnosing and treating autoimmune diseases and cancer by targeting these viral remnants in the human genome.
Researchers discovered that our cells hide their own RNA from the immune system by coating it with sugars, preventing unnecessary immune responses and potentially informing treatments for autoimmune diseases like lupus.
Emerging research suggests that sunlight, particularly UVB rays, may have health benefits beyond skin health, including dampening inflammation, aiding autoimmune conditions like multiple sclerosis, and improving cardiovascular health by releasing nitric oxide. While excessive sun exposure increases skin cancer risk, moderate exposure with precautions can be beneficial for overall health, and vitamin D production is just one aspect of sunlight's positive effects.
Bristol Myers Squibb and Bain Capital have created a new independent biopharmaceutical company, NewCo, focused on developing innovative immunology therapies for autoimmune diseases, with five assets licensed from BMS and a $300 million investment led by Bain Capital, aiming to address unmet medical needs.